Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Astellas Pharma Inc
Astellas Pharma Inc_20100114

Astellas Pharma Inc patents

Recent patent applications related to Astellas Pharma Inc. Astellas Pharma Inc is listed as an Agent/Assignee. Note: Astellas Pharma Inc may have other listings under different names/spellings. We're not affiliated with Astellas Pharma Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Astellas Pharma Inc-related inventors

Date Astellas Pharma Inc patents (updated weekly) - BOOKMARK this page
11/30/17Novel genetically engineered vaccinia viruses
11/16/17Therapeutic agent for pain
10/26/17Novel bispecific antibody format
10/12/172-aminothiazole derivative or salt thereof
09/28/17Novel pharmaceutical composition for prevention and/or treatment of urinary incontinence
09/07/17Novel anti-human tie-2 antibody
08/17/17Pharmaceutical composition for modified release
08/17/17Tetrahydroisoquinoline derivatives
08/10/17Formulations of enzalutamide
08/10/17Novel anti-human igb antibody
07/13/17Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient
07/13/172-acylaminothiazole derivative or salt thereof
07/06/17Pyridine derivative
06/01/17Nitrogen-containing aromatic heterocyclic compound
05/25/17Pharmaceutical composition for oral administration
03/30/17Granular pharmaceutical composition
02/23/17Tetrahydrooxepinopyridine compound
02/02/17Formulations of enzalutamide
01/19/17Method for treating premature ejaculation and controlling premature ejaculation treatment device
12/29/16Novel fgfr3 fusion
12/22/16Novel anti-human pai-1 antibody
12/08/16Novel bispecific antibody binding to human tlr2 and human tlr4
11/24/16Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient
11/17/16Indole compound
11/03/16Novel anti-human bdca-2 antibody
09/22/16Method of producing fr901228
08/11/16Nitrogen-containing bicyclic aromatic heterocyclic compound
08/04/16Novel anti-human tie-2 antibody
07/21/16Novel anti-human tslp receptor antibody
07/14/16Pharmaceutical composition having pyrimidine compound as active ingredient
07/14/16Pharmaceutical composition having pyrimidine compound as active ingredient
07/07/16Method for creating endometriotic cells and endometriosis model animal
06/30/16Pharmaceutical composition for modified use
05/19/16Method for producing renal progenitor cells, and drug comprising the same
04/28/16Medicinal composition for inhibiting formation and/or enlargement of cerebral aneurysm or shrinking same
02/18/16Pharmaceutical composition for oral administration
02/18/16Novel anti-human tslp receptor antibody
02/04/16Guanidinobenzoic acid ester compound
01/07/162-acylaminothiazole derivative or salt thereof
12/24/15Pharmaceutical composition for treating or preventing stress urinary incontinence or mixed urinary incontinence, and screening compound comprised in said pharmaceutical composition
11/05/15Benzazepine compound
10/29/15Orally administered medical composition
09/24/15Bicyclic nitrogen-containing aromatic heterocyclic amide compound
09/17/15Method for producing sulfonyl amidine compound
08/20/15Sulfur-containing bicyclic compound
08/20/15Imidazopyridine compounds
08/13/15Method of producing fr901228
08/06/15Novel anti-human ngf antibody
07/23/15Guanidine compound
07/23/15Indole carboxamide derivative
07/09/15Filaggrin production promoter, therapeutic agent for diseases associated with reduction in production of filaggrin, and screening for said therapeutic agent
07/02/15Eml4-alk fusion gene
05/21/15Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5h-1-benzazepine compound and intermediate used in the method
05/14/15Benzothiophene compound
05/07/15Nitrogen-containing bicyclic aromatic heterocyclic compound
05/07/15Nitrogen-containing bicyclic aromatic heterocyclic compound
05/07/15Pharmaceutical composition for modified release
05/07/15Novel anti-human il-23 receptor antibody
04/23/15Sulfur-containing bicyclic compound
02/12/15Heterocyclic acetamide compound
01/29/15Novel fgfr3 fusion
01/29/15Aminoalkyl-substituted n-thienylbenzamide derivative
01/29/15Pharmaceutical composition containing mirabegron
12/25/14Guanidinobenzoic acid compound
12/25/14Formulations of enzalutamide
Patent Packs
12/18/14Diamino heterocyclic carboxamide compound
12/11/14Benzothiophene compound
11/20/14Novel anti-human ctgf antibody
11/06/14Tetrahydrobenzothiophene compound
10/30/14Pyrazinecarboxamide compound
10/23/14Heterocyclic acetamide compound
09/18/14Crystal of androgen receptor antagonistic compound
09/18/14Novel anti-human il-23 receptor antibody
09/04/14Bicyclic heterocyclic compound
08/28/14Granular pharmaceutical composition
08/14/14Novel anti-human ngf antibody
08/07/14Method for detecting novel fgfr4 mutant
06/26/14Chromane compounds
06/05/14Novel anti-human ngf antibody
05/22/14Nitrogen-containing aromatic heterocyclic compound
Patent Packs
04/10/14Guanidine compound
03/27/14Imidazopyridine compounds
03/06/14Method for treating cancer by combined use of drugs
12/19/13Method for producing di(arylamino)aryl compound and synthetic intermediate therefor
11/28/13Tetrahydroisoquinoline derivative
11/21/13Pyrimidine compound
10/03/13Method for determining lipophilicity
09/05/13Substituted amide compound
08/29/13Pyrazoloquinoline compound
08/08/13Pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency
08/01/13Antagonist for mutant androgen receptor
06/27/13Therapeutic agent for pain
06/20/13Eml4-alk fusion gene
06/13/13Heterocyclic compound
06/13/13Pharmaceutical composition for treating overactive bladder
06/06/13Guanidine compound
06/06/13Fused ring pyridine compound
05/30/13Detection novel ret fusion
05/30/13Solid dispersion comprising triazole compound
04/25/13Method of treating diabetes, metabolic syndrome and obesity using phenylacetamide derivative
04/25/13Crystal of fused pyridine compound salt
04/18/13Di(arylamino)aryl compound
04/04/13Quinoxaline compound
03/28/132-acylaminothiazole derivative or salt thereof
03/07/13Benzazepine compound
03/07/13Crystal of di(arylamino)aryl compound
02/28/13Imidazo[1,2-a]pyridine derivative
02/28/13Tetrahydrobenzothiophene compound
01/31/13Tetrahydrobenzothiophene compound
Social Network Patent Pack
01/24/13Method of preventing and/or treating diabetic neuropathy
01/10/13Benzazepine compound
11/01/12Benzamide compound
09/06/12Method of producing fr901228
09/06/12Method of producing fr901228
08/23/12Compound ws 727713
07/19/12Glycine compound
07/19/12Substituted amide compound
07/12/122h-chromene compound and derivative thereof
06/28/12Hetero ring derivative
Patent Packs
05/31/12Quinolone derivative or pharmaceutically acceptable salt thereof
04/12/12Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/12/12Methods for maintaining effective plasma concentrations of a pharmaceutical
03/22/12Pharmaceutical composition for modified release
03/08/12Polyketide compound
02/23/12Diacylethylenediamine compound
02/09/12Condensed pyrrolopyridine derivative
01/26/12Novel producing optically active pyrrolidine compound
12/29/11Quinoxaline compound
12/15/11Package of solid pharmaceutical preparation
12/01/11Diaminopyrimidinecarboxamide derivative
11/24/11Pharmaceutical composition comprising solifenacin
11/17/11Sustained release formulation for tacrolimus
11/17/11Agent for treating or preventing digestive ulcer
11/03/11Benzazepine compound
09/29/11Animal model of an ejaculation-like reflex
09/29/11Pharmaceutical composition for modified release
09/22/112h-chromene compound and derivative thereof
09/22/114,6-diaminonicotinamide compound
09/22/11Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
08/25/11Cyclic depsipeptide compound and use thereof
08/25/11Bicyclic acylguanidine derivative
08/18/11Sulfonamide compounds or salts thereof
08/18/11Agent for preventing or treating zoster-associated pain
07/07/11Heterocyclic carboxamide compounds
07/07/11Novel salt of morpholine derivative
06/30/11Method for treatment of irritable bowel syndrome
06/30/11Antitumor agent
06/23/11Novel pharmaceutical composition for treating nociceptive pain
06/16/11Controlled release dosage form of tacrolimus
Patent Packs
06/16/11Amide compound
05/05/11Aminosugar compound and process for production thereof
05/05/11Triazole derivative or salt thereof
03/24/1117betahsd type 5 inhibitor
03/17/11Composition of solifenacin or salt thereof for use in solid formulation
03/10/11Humanized anti-human alpha 9-integrin antibody
03/03/11Pyrimidine compound
02/17/11Heterocyclic janus kinase 3 inhibitors
02/10/11Agent for preventing and/or treating vascular diseases
02/03/11Amide compounds
01/13/11Indolinone compound
11/25/10Compound ws 727713
11/11/10New cyclic peptide compounds
11/11/10Phenylacetamide derivative
10/28/10Solid pharmaceutical composition containing solifenacin amorphous form
10/21/10Fused indane compound
10/14/10Pharmaceutical composition for improving lower urinary tract symptoms
10/07/10Polypeptide compound
10/07/10Quinolone derivative
10/07/10Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
Social Network Patent Pack
10/07/10Novel pharmaceutical composition for treatment of schizophrenia
09/30/10Azolecarboxamide compound or salt thereof
09/23/10Pharmaceutical composition for treating overactive bladder
09/16/10Pharmaceutical composition for oral administration
09/09/10Tetrahydroisoquinolin-1-one derivative or salt thereof
09/02/10Immune response induction method
09/02/102-acylaminothiazole derivative or salt thereof
09/02/102-acylaminothiazole derivative or salt thereof
08/26/10Fused heterocycles as lck inhibitors
08/26/10Pain remedy containing rock inhibitor
08/26/10Ornithine derivative
07/22/10Gastrointestinal-specific multiple drug release system
07/08/10Benzimidazolylidene propane-1,3-dione derivative or salt thereof
07/01/101-substituted tetrahydroisoquinoline compound
07/01/10Hetero compound
06/17/10Granular pharmaceutical composition of atorvastatin for oral administration
06/10/10Pharmaceutical composition for modified release
06/10/10Pharmaceutical composition for oral administration
06/10/10Neurite formation promoter
06/10/10Method for screening agents for the treatment of diabetes
Social Network Patent Pack
06/03/10Granular pharmaceutical composition for oral administration
05/27/10Screening prokinetic agent
05/06/10Bicyclic heterocyclic compound
05/06/10Novel preventive and/or therapeutic agent for diabetic neuropathy
04/29/10Aza-bridged-ring compound
04/29/10Condensed pyridine compound
04/22/10Di(arylamino)aryl compound
04/08/10Novel preventive and/or therapeutic agent for neuropathic pain
03/18/10N-hydroxyacrylamide compounds
03/11/10Light-stable solid pharmaceutical composition of ramosetron
02/18/10Compositions and methods for treating thrombocytopenia
02/04/10Piperidine derivative or salt thereof
02/04/10Method of searching for ligand
01/14/10Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents
12/24/09Reverse targeting lipid vesicle
12/17/09Sulfonamide compound or salt thereof
11/19/09Azolecarboxamide derivative
11/12/09Thiazole derivative
10/29/09Benzamide derivative or salt thereof
10/29/09Heterocyclic janus kinase 3 inhibitors
10/29/09Amido derivatives-contained pharmaceutical composition
10/22/09Method of treating cancer by co-administration of anticancer agents
10/22/09Method of producing fr901228
10/22/09Heterocyclic janus kinase 3 inhibitors
10/22/09Method of producing fr901228
09/24/09Pharmaceutical composition containing lipophilic substance which inhibits il-2 production
09/24/09Ace inhibitor-vasopressin antagonist combinations
09/17/092-aminobenzamide derivative
08/13/09Crystals of benzoxadiazole derivative
08/06/09Quinolone derivative or pharmaceutically acceptable salt thereof
Social Network Patent Pack
07/23/09Aminoindane derivative or salt thereof
07/16/09Propane-1,3-dione derivative or salt thereof
06/18/09Method of producing fr901228
06/11/09Caspase inhibitor
05/28/09Substituted benzene derivatives or salts thereof
05/21/09Preventive or remedy for bowel disease
05/21/09Pharmaceutical agent comprising solifenacin
05/21/09Acylaminopiperidine compound
05/14/09Quinolone derivative or salt thereof
05/07/09Model animal of schizophrenia
04/23/09Depsipeptide-containing injection solution
04/23/09Amide derivatives as rock inhibitors
04/23/09Pharmaceutical composition for therapy of interstitial cystitis
04/09/09Therapeutic agent for irritable bowel syndrome
04/09/09Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
03/26/09Triazole derivative or a salt thereof
03/19/09Sustained-release formulation
03/19/09Hetero compound
03/05/09Amide derivative or salt thereof
02/26/09Benzene derivative or salt thereof
02/26/09Hdac inhibitor
02/19/09Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
02/05/09Pyrrole derivative or salt thereof
02/05/09Manufacturing a pharmaceutical composition for controlled release of an active substance
02/05/09Agent for treating or preventing digestive ulcer
01/14/10Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Astellas Pharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Astellas Pharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by